Boyao Chen

Boyao Chen

Auto-generated profile, based on publicly available information

Boyao Chen

Key Laboratory of Endocrine Glucose and Lipids Metabolism and Brain Aging, Ministry of Education, Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China (B.C., X.H., Y.C., P.L., L.G.).

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2026 in Japanese Journal of Radiology
Verified
Journal Article
Closed access
PDF file
FZFushuai Zhang
Fushuai Zhang
RWRui Wu
Rui Wu
振程振宇 程
振宇 程
NZNan Zhang
Nan Zhang
YCYena Che
Yena Che
LGLingfei Guo
Lingfei Guo

13 November 2025 in Human Brain Mapping
Verified
Journal Article
Open access
BCBoyao Chen
Boyao Chen
MLMeng Li
Meng Li
LYLinfeng Yang
Linfeng Yang
TCTao Chen
Tao Chen
QZQihao Zhang
Qihao Zhang
LGLingfei Guo
Lingfei Guo
Preeclampsia is a severe pregnancy complication that can cause brain injury, yet early detection of related cognitive deficits remains challenging. Therefore, in order to investigate alterations in choroid plexus volume (CPV) and susceptibility values of the choroid plexus (ChP) obtained from quantitative susceptibility mapping (QSM) in preeclampsia patients, we enrolled 281 participants, comprising 98 nonpregnant healthy controls (NPHC), 85 pregnant healthy controls (PHC), and 98 patients with preeclampsia. All participants were scanned on a 1.5 T MR scanner. The results of clinical characteristics and cognitive tests were collected from all the participants. One‐way ANOVA tests were used to analyze the differences in CPV and susceptibility values of ChP among the three groups. Multiple linear regression analysis was used to find the factors that influenced CPV and its susceptibility values, as well as cognitive decline. Additionally, receiver operating characteristic (ROC) analysis was employed to evaluate the diagnostic performance of the two imaging measures. Preeclampsia patients exhibited smaller CPV and higher susceptibility values compared to the other groups ( p < 0.001; p < 0.001). Significant negative correlations were observed between body mass index (BMI), mean arterial pressure and CPV/eTIV ( β = −0.100, 95% CI = −0.158 ~ −0.042, p = 0.001; β = −0.022, 95% CI = −0.033 ~ −0.011, p < 0.001). Additionally, significant positive correlations were observed between BMI ( β = 0.455, 95% CI = 0.125 ~ 0.786, p = 0.007), mean arterial pressure ( β = 0.170, 95% CI = 0.107 ~ 0.232, p < 0.001), hemoglobin ( β = 0.152, 95% CI = 0.051 ~ 0.254, p = 0.003) and susceptibility values of ChP. Furthermore, CPV/eTIV and susceptibility values of ChP could be independent contributing factors of scores of TMT. The combination of CPV, susceptibility values of ChP, BMI and gestational week could distinguish preeclampsia from pregnant groups (AUC = 0.787, 95% CI = 0.722–0.853, p < 0.001) as well as distinguish individuals with cognitive decline from preeclampsia patients (AUC = 0.737, 95% CI = 0.621–0.844, p < 0.001). These findings indicate that smaller CPV and higher susceptibility values characterize preeclampsia and may serve as auxiliary indices for its diagnosis and related cognitive decline.

2 July 2026 in Hypertension
Verified
Journal Article
Open access
BCBoyao Chen
Boyao Chen
MLMeng Li
Meng Li
TCTao Chen
Tao Chen
QZQihao Zhang
Qihao Zhang
振程振宇 程
振宇 程
LGLingfei Guo
Lingfei Guo
BACKGROUND: Preeclampsia is associated with long-term cognitive dysfunction, potentially linked to cerebral iron deposition. This study investigated striatal iron alterations using quantitative susceptibility mapping and their relationship with cognitive function in patients with preeclampsia. METHODS: This cross-sectional study enrolled 321 participants, including nonpregnant and pregnant healthy controls, and patients with preeclampsia. Participants underwent the Montreal Cognitive Assessment, Trail Making Test, and 1.5 T brain magnetic resonance imaging. Striatal iron content was quantified using quantitative susceptibility mapping reconstructed with a morphology-enabled dipole inversion algorithm. RESULTS: Preeclampsia patients showed poorer executive function (Trail Making Test part [A+B]: partial η 2 =0.170; part B: partial η 2 =0.100) and elevated nucleus accumbens magnetic susceptibility (all P <0.001). Age ( β =0.744, P <0.001) and hematocrit ( β =0.846, P =0.011) were independently associated with iron levels. In addition, significant interactions between nucleus accumbens susceptibility values and preeclampsia status were observed for log-transformed Trail Making Test completion times (part [A+B]: interaction β =0.388, P =0.006; part B: interaction β =0.424, P =0.003), indicating that elevated iron specifically exacerbates executive vulnerability in preeclampsia. CONCLUSIONS: Nucleus accumbens iron level is elevated in preeclampsia and correlates with executive performance. Although the cross-sectional design limits causal conclusions, these findings highlight nucleus accumbens iron deposition as a key pathological feature underlying preeclampsia-related cerebral involvement.